ZANGHI', Mariangela
 Distribuzione geografica
Continente #
NA - Nord America 1.777
EU - Europa 1.327
AS - Asia 859
SA - Sud America 256
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 4.241
Nazione #
US - Stati Uniti d'America 1.757
SG - Singapore 351
SE - Svezia 311
CN - Cina 290
IE - Irlanda 289
BR - Brasile 234
IT - Italia 223
HK - Hong Kong 115
DE - Germania 103
UA - Ucraina 85
GB - Regno Unito 61
FR - Francia 56
PL - Polonia 54
FI - Finlandia 50
RU - Federazione Russa 34
VN - Vietnam 27
BE - Belgio 23
IN - India 21
AR - Argentina 9
CA - Canada 8
ZA - Sudafrica 8
BD - Bangladesh 7
MX - Messico 7
NL - Olanda 6
ES - Italia 5
AL - Albania 4
CO - Colombia 4
IQ - Iraq 4
JO - Giordania 4
JP - Giappone 4
MA - Marocco 4
NO - Norvegia 4
PK - Pakistan 4
TR - Turchia 4
UZ - Uzbekistan 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
IR - Iran 3
LT - Lituania 3
SA - Arabia Saudita 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BY - Bielorussia 2
DZ - Algeria 2
EC - Ecuador 2
HR - Croazia 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
PE - Perù 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BH - Bahrain 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
GT - Guatemala 1
ID - Indonesia 1
IL - Israele 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
TH - Thailandia 1
TN - Tunisia 1
Totale 4.241
Città #
Dublin 287
Ashburn 215
Chandler 212
Dallas 192
Nyköping 169
Singapore 168
Jacksonville 165
Beijing 129
Hong Kong 115
Ann Arbor 72
New York 54
Warsaw 52
Dearborn 47
Los Angeles 45
Messina 42
The Dalles 42
Medford 40
Princeton 40
Cambridge 39
Des Moines 33
Boardman 29
Munich 27
Brussels 23
Woodbridge 23
Buffalo 21
São Paulo 20
Lancaster 19
San Mateo 17
Tianjin 17
Jinan 15
Wilmington 14
Pune 12
Hebei 11
Zhengzhou 10
Ho Chi Minh City 9
Houston 9
Nanjing 9
Taizhou 9
Frankfurt am Main 8
Rio de Janeiro 8
Shenyang 8
Turku 8
Denver 7
Johannesburg 7
London 7
Belo Horizonte 6
Brooklyn 6
Chicago 6
Council Bluffs 6
Düsseldorf 6
Moscow 6
Nanchang 6
Ningbo 6
Redondo Beach 6
Seattle 6
Stockholm 6
Brasília 5
Hangzhou 5
Hanoi 5
Leawood 5
Monmouth Junction 5
Montreal 5
San Francisco 5
Amman 4
Amsterdam 4
Auburn Hills 4
Augusta 4
Guangzhou 4
Jiaxing 4
Ribeirão Preto 4
Tashkent 4
Atlanta 3
Belém 3
Bremen 3
Brockport 3
Changsha 3
Cuiabá 3
Curitiba 3
Genova 3
Goiânia 3
Guarulhos 3
Helsinki 3
Joinville 3
João Pessoa 3
Las Vegas 3
Mexico City 3
Milan 3
Norwalk 3
Oslo 3
Rome 3
Salvador 3
Santo André 3
Taiyuan 3
Tirana 3
Trepuzzi 3
Baku 2
Bishkek 2
Boston 2
Cabo Frio 2
Campo Grande 2
Totale 2.720
Nome #
Linfoscintigrafia ascellare preoperatoria nel cancro della mammella. 273
A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): old successes and future perspectives 173
zd1839"iressa" in heavily pretreated patients with advaned/metastatic non-small cell lung cancer(NSCLC):assessment of tolerability and the clinical benefit 158
Epirubucin (EPI) and Paclitaxel (TAX) in advanced breast cancer.a phase II studyi 136
Androgen receptor (AR), E-cadherin, and Ki-67 as prognostic markers in triple-negative breast cancer (TNBC). 136
A PHASE II STUDY (21 DAY REGIMEN) OF GEMCITABINE AND CISPLATIN IN TRANSITIONAL CELL CARCINOMA OF BLADDER 123
Gemcitabine (GEM) and cisplatin (CIS) in advanced/metastatic transitional cell carcinoma (TCC) of bladder:phase II study 122
A new method for titration of oral transmucosal fentanyl citrate (OTFC) starting dose in cancer patients. 118
Second line chemoterapy in patients with metastatic colorectal cancer(MCRC):our experience 115
Beta=interferon in the treatment of 14 patie nts with advanced colorectal carcinoma. J Exp Pathol. 1987 Summer;3(4):603-5. No abstract available. PMID: 3454807 [PubMed - indexed for MEDLINE] 113
ZD 1839 IRESSA IN HEAVILY PRETREATED PATIENTS WITH ADVANCED/METASTATIC NON SMALL CELL LUNG CANCER:ASSESSMENT OF TOLERABILITY AND CLINICAL BENEFIT 113
INCIDENZA DELL'ONCOTIPO POLMONARE NELLO STESSO TERRITORIO IN TRIENNI DIFFERENTI- 1983/84/85 E 1993/94/95. Eur. Jour. of Oncology Vol. 2, n° 4, 1997. 111
Gemcitabine (GEM) and cisplatin (Cis) in advanced/metastatic transitional cell carcinoma (TCC) of bladder: Phase II study 110
gemcitabine and pegylated liposomial doxorubicin in recurrent epithelial ovarian cancer (REOC).Preliminary report a phase II study 110
Second-line therapy in advanced non-small cell lung cancer: Cytotoxic agents or tyrosine kinase inhibitors? Our experience. 109
Etoposide, l-leucovorin and fluorouracil (ELF) regimen in metastatic gastric cancer: a phase II study. J Chemother. 1999 Feb;11(1):74-7. PMID: 10078785 [PubMed - indexed for MEDLINE] 109
Third generation EGFR TKIs in EGFR-mutated NSCLC: Where are we now and where are we going 109
NSCLC and HER2: between lights and shadows 107
Etoposide, l-leucovorin and fluorouracil (ELF) regimen in metastatic gastric cancer: A phase II study 104
Correlation between serum magnesium levels and skin toxicity during cetuximab treatment in squamous cell carcinoma of head and neck cancer (SCCHN): the role of weekly intravenous magnesium supplementation. 102
May the istotype influence the response to pemetrexed in patients with non small cell lung cancer? Preliminary data of our clinical experience. 99
Dati preliminari sulla caratterizzazione molecolare dei casi di melanoma familiare di origine siciliana. 99
Incidenza dell’oncotipo polmonare nello stesso territorio in trienni differenti 1983/84/85 e 1993/94/95. 97
Predicting sensitivity of non small cell lung cancer to gefitinib and erlotinib: is there still a role for clinical factors ? 96
Dati preliminari sulla caratterizzazione molecolare dei casi di melanoma familiare di origine siciliana. 95
LINFOSCINTIGRAFIA ASCELLARE PREOPERATORIA DEL CANCRO DELLA MAMMELLA. Acta Oncologica - Voi. XVI – n. 1, 1995. 93
Dati preliminari sulla caratterizzazione molecolare dei casi di melanoma familiare di origine siciliana. 93
IL-33/IL-31 axis: A new pathological mechanism for epidermal growth factor receptor tyrosine kinase inhibitors-associated skin toxicity? 92
Gemcitabine and liposomal doxorubicin in the salvage treatment of ovarian cancer: Updated results and long-term survival. 90
Overview and new strategies in metastatic breast cancer (MBC) for treatment of tamoxifen-resistant patients. 89
Impact of single-nucleotide polymorphisms in genes coding for folate pathway enzymes on efficacy/toxicity of gemcitabine and pemetrexed based therapy in advanced non small cell lung cancer (NSCLC): new prospectives for old markers. 89
OUR EXPERIENCE ON THE EFFECTS OF TAMOXIFEN ON BLOOD COAGULATION IN PATIENTS OPERATED FOR BREAST CANCER Folia Oncologica vol.XIV-n.2-3 (Aprile-Settembre)-1991 87
Role of Androgen Receptor (AR), Ki 67 and E-cadherin as prognostic markers in Triple Negative Breast Cancer (TNBC) 85
Induction chemotherapy to weekly paclitaxel concurrent with curative radiotherapy in stage IV (MO) unresectable head and neck squamous cell carcinoma: a dose escalation study 85
Molecular and clinical analysis of predictive biomarkers to anti-EGFR inhibitors in metastatic colorectal cancer (mCRC): Interaction among early tumor shrinkage, skin toxicities, and RAS status. 83
PHASE II STUDY OF LIPOSOMAL DOXORUBICIN AND GEMCYTABINE IN THE TREATMENT OF RECURRENT OVARIAN CANCER 82
Safety of trastuzumab, alone or in combination, in elderly patients with HER2-positive breast cancer: A 5-year case series. 76
Safety of Zoledronic acid in bone metastatic breast cancer patients: A retrospective analysis. 74
Safety of trastuzumab-containing therapies in elderly women with metastatic breast cancer. 61
The risk of toxicities from trastuzumab, alone or in combination, in an elderly breast cancer population. 38
null 22
Totale 4.276
Categoria #
all - tutte 15.053
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.053


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021185 0 0 0 0 0 30 17 24 11 37 51 15
2021/2022332 4 57 6 10 6 1 25 9 3 86 40 85
2022/2023879 70 93 39 68 65 77 7 69 363 0 20 8
2023/2024227 20 42 7 24 12 81 14 14 0 4 0 9
2024/2025793 6 7 14 52 27 29 7 145 210 55 68 173
2025/2026881 164 147 185 135 226 24 0 0 0 0 0 0
Totale 4.276